Contineum Therapeutics, Inc. · NASDAQ:CTNM
Ra Capital Management, L.P.'s stake in Contineum Therapeutics, Inc. fell to 4.00% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Ra Capital Management, L.P.'s stake in Contineum Therapeutics, Inc. fell to 4.00%, 1,296,012 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.00%
- Shares
- 1,296,012
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 4.00% | 1,296,012 |
| Peter Kolchinsky | 4.00% | 1,296,012 |
| Rajeev Shah | 4.00% | 1,296,012 |
| RA Capital Healthcare Fund, L.P. | 4.00% | 1,296,012 |
Source
Related
- Contineum Therapeutics, Inc.
- Ra Capital Management, L.P.
- Contineum Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026
- Schedule 13G · Ra Capital Management, L.P. · Jul 25, 2025
- Schedule 13G · Trails Edge Capital Partners, LP · Oct 22, 2026
- Form 4 · Stengone Carmine N. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Stengone Carmine N. · Aug 3, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026